Literature DB >> 6508309

Acute toxicity of aminoglycoside antibiotics as an aid in detecting botulism.

Y C Wang, D H Burr, G J Korthals, H Sugiyama.   

Abstract

Gentamicin sulfate or neomycin sulfate injected intraperitoneally into 24- to 27-g mice at a dose of 6.2 mg per mouse elicited botulism-like responses in less than 30 min, but a dose of 3.1 mg per mouse had no observable effect. The normally nontoxic 3.1-mg aminoglycoside dose aggravated the illness induced by an earlier injection of Clostridium botulinum type A or B toxin; it was usually lethal in 2 to 20 min if the preexisting illness was moderate to severe and worsened the condition of mice for about 30 min if the preexisting botulism was mild. The aminoglycoside had no effect when given shortly after the botulinum toxin was injected intraperitoneally; the sensitized state followed a latent period. It rapidly produced botulism-like effects when given to mice which had responded to a mixture of botulinum toxin and another mouse toxic agent with an illness that did not include signs of botulism. An unexpected illness devoid of botulism-like effects was encountered during intestinal colonization of mice by C. botulinum. The appearance of botulism-like signs soon after 3.1 mg of gentamicin sulfate was injected supported other suggestions that this illness included botulism that was masked by the effects of a second cause.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6508309      PMCID: PMC241656          DOI: 10.1128/aem.48.5.951-955.1984

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  10 in total

1.  Molecular forms of neurotoxins in proteolytic Clostridium botulinum type B cultures.

Authors:  B R Dasgupta; H Sugiyama
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

2.  The nature of neuromuscular block produced by neomycin and gentamicin.

Authors:  O Vital Brazil; J Prado-Franceschi
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-05

Review 3.  Clostridium botulinum neurotoxin.

Authors:  H Sugiyama
Journal:  Microbiol Rev       Date:  1980-09

Review 4.  Infant botulism.

Authors:  S S Arnon
Journal:  Annu Rev Med       Date:  1980       Impact factor: 13.739

5.  Improved procedure for crystallization of Clostridium botulinum type A toxic complexes.

Authors:  H Sugiyama; L J Moberg; S L Messer
Journal:  Appl Environ Microbiol       Date:  1977-04       Impact factor: 4.792

6.  Susceptibility to enteric botulinum colonization of antibiotic-treated adult mice.

Authors:  D H Burr; H Sugiyama
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

7.  Potentiation of Clostridium botulinum toxin aminoglycoside antibiotics: clinical and laboratory observations.

Authors:  J I Santos; P Swensen; L A Glasgow
Journal:  Pediatrics       Date:  1981-07       Impact factor: 7.124

8.  Clinical characteristics of infant botulism in the United States: a study of the non-California cases.

Authors:  R Wilson; J G Morris; J D Snyder; R A Feldman
Journal:  Pediatr Infect Dis       Date:  1982 May-Jun

9.  Potentiation of neuromuscular weakness in infant botulism by aminoglycosides.

Authors:  C L'Hommedieu; R Stough; L Brown; R Kettrick; R Polin
Journal:  J Pediatr       Date:  1979-12       Impact factor: 4.406

10.  Resistance of mice with limited intestinal flora to enteric colonization by Clostridium botulinum.

Authors:  C L Wells; H Sugiyama; S E Bland
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

  10 in total
  4 in total

1.  Iridium piano stool complexes with activity against S. aureus and MRSA: it is past time to truly think outside of the box.

Authors:  Christine M DuChane; George W Karpin; Marion Ehrich; Joseph O Falkinham; Joseph S Merola
Journal:  Medchemcomm       Date:  2019-05-14       Impact factor: 3.597

Review 2.  Botulinum neurotoxin type A free of complexing proteins (XEOMIN) in focal dystonia.

Authors:  Wolfgang H Jost; Jörg Blümel; Susanne Grafe
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021.

Authors:  Agam K Rao; Jeremy Sobel; Kevin Chatham-Stephens; Carolina Luquez
Journal:  MMWR Recomm Rep       Date:  2021-05-07

Review 4.  Therapeutic applications of botulinum neurotoxins in head and neck disorders.

Authors:  Ahmad Alshadwi; Mohammed Nadershah; Timothy Osborn
Journal:  Saudi Dent J       Date:  2014-12-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.